Suicide

Lithium significantly reduces suicidal ideation and attempts in bipolar and major depressive disorder patients, enhancing long-term treatment outcomes.

Seena Fazel, MD, reviews the growth and challenges of suicide risk-prediction models, emphasizing the need for rigorous validation and clinical integration.

Chatbots risk validating suicidal thoughts, highlighting the urgent need for ethical programming to prioritize user safety and human connection.

Veterans face significant PTSD challenges, with tailored treatments and ongoing research essential for improving their mental health outcomes.

The 2026 NCCHC Standards revolutionize mental health care in correctional facilities, emphasizing ethical practices, interdisciplinary collaboration, and patient dignity.

Learn how screening for suicidality is essential, and how to open conversations with patients on this sensitive topic.

Emergency departments face challenges in detecting suicidality among patients with trauma, highlighting the need for effective screening and intervention strategies.

AI chatbots raise critical concerns in mental health, revealing risks of suicide ideation, maladaptive thinking, and the need for clinician awareness and intervention.

Socrates’ suicide as an affirmative choice.

Recent research links nighttime screen use and easy medication access to increased suicide attempts among adolescents, highlighting urgent mental health concerns.

Clinicians face challenges in suicide risk assessment, especially with patients denying intent before tragic outcomes. Understanding lethal suicide deniers is crucial.

Allen Frances, MD, introduces his new weekly series for Psychiatric Times: “AI Chatbots: The Good, the Bad, and the Ugly.”

Oregon's "Create Resilience" Youth Art Contest celebrates creativity in mental health, showcasing powerful youth submissions that inspire hope and connection.

Christine Yu Moutier, MD, discusses suicide prevention strategies, highlighting risk factors and the importance of culturally competent care for vulnerable populations.

Today is World Suicide Prevention Day. Media training emerges as a vital tool for psychiatrists, enhancing suicide prevention efforts and combating misinformation in mental health.

A new mobile app has been found to reduce suicidal behavior post hospitalization in patients at high suicide risk.

NRX-100, a preservative-free ketamine, is granted expanded access for treatment of suicidal ideation in depression, offering new hope for patients.

OpenAI acknowledges ChatGPT's risks to psychiatric patients and commits to improving safety measures, but skepticism about their sincerity remains.

Explore the latest research on athlete mental health, highlighting concussion recovery, anti-doping stress, and the protective role of competitive sports.

AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.

NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.

Youth with neurodevelopmental disorders face significant suicide risks.

The debate over palliative psychiatry's role in advocating for psychiatric euthanasia continues, raising ethical concerns about mental health care and patient autonomy.

The complex ethics of dying, death, and assisted dying lead to debates on terminology and implications for patient autonomy and suffering.